Capital Vitality
SCRIMED turns revenue, moat, and funding readiness into one governed growth lane.
This lane packages sellable revenue capabilities, competitive proof, investor diligence milestones, and funding workstreams while keeping securities, valuation, legal, reimbursement, PHI, security, and live-care boundaries explicit.
Boundary
Growth readiness is not a funding solicitation, valuation claim, or approval claim.
SCRIMED Capital Vitality organizes revenue capabilities, competitive moat evidence, investor-readiness milestones, funding workstreams, and retained external-review gates. It strengthens commercial execution and diligence readiness, but it is not investment advice, securities offering material, audited financial reporting, valuation assurance, legal advice, tax advice, reimbursement assurance, customer revenue guarantee, security certification, regulatory approval, PHI processing approval, production connector approval, or live clinical care authorization.
01investor-ready-readiness-materials-no-securities-offer
02not-securities-offering-material
03not-investment-advice
04not-valuation-assurance
Revenue capability
Sellable paths are packaged around synthetic, governed, and review-only value before production authority.
packaged
Synthetic Atlas Pilot
30 to 90 day governed synthetic pilot with executive findings and production-readiness gates.
Health systems, payers, public-sector health teams, and enterprise innovation sponsors
- Packaged as a premium fixed-fee pilot before any protected enterprise or production-license commitment.
- Pilot evidence remains synthetic or protected-evaluation only until buyer-specific live controls are approved.
- Next: Use the Deal Room and Pilot Intake to qualify sponsor, workflow scope, review team, and success metrics.
- Proof routes: /product, /pilot-deal-room, /pilots, /pricing
active
Workflow Intelligence Assessment
Short paid assessment that maps workflow friction, AI readiness, governance gaps, and pilot candidates.
Clinical operations, access, revenue cycle, documentation, and transformation leaders
- Fixed-scope assessment with clear upgrade path into Synthetic Atlas Pilot.
- Findings are operational intelligence for human leaders, not medical, legal, reimbursement, or accounting advice.
- Next: Keep assessment outputs tied to proof routes, governance gates, and buyer-approved baselines.
- Proof routes: /pricing, /product, /pilot, /sales-operations
packaged
AI Readiness + Governance Audit
Readiness engagement for claims control, privacy posture, auditability, role controls, runtime safety, and approval gates.
Compliance, security, legal, clinical governance, innovation, and executive sponsors
- Assessment fee that can expand into protected pilot controls and enterprise diligence work.
- Readiness audit does not certify HIPAA, SOC 2, HITRUST, FDA, ONC, security posture, or legal compliance.
- Next: Route any certification, regulatory, or legal claim through qualified external reviewers.
- Proof routes: /approvals-readiness, /boundary-resolution, /clinical-authority-readiness, /trust-center
packaged
Clinical Operations Automation Blueprint
Blueprint package for agent responsibilities, connector plan, review queues, safety controls, and staged deployment path.
Hospitals, clinics, payers, and public-sector health programs planning phased automation
- Strategy and implementation-planning package that precedes protected pilot or enterprise license.
- Blueprint remains review-only and does not authorize live clinical workflow execution or production connectors.
- Next: Translate each automation candidate into blocked actions, human checkpoints, and audit evidence.
- Proof routes: /agents, /workflows, /healthcare-intelligence-os, /interoperability
protected-gated
Protected Buyer Diligence Rooms
Paid buyer-specific diligence packaging with proof packets, release controls, and metadata-only evidence routing.
Enterprise buyers, procurement, security reviewers, investor diligence teams, and executive sponsors
- Bundled into enterprise pilot/procurement motion; future premium service when release authority is retained.
- External sharing remains blocked until release decisions, reviewer signoffs, recipient controls, and access-log reconciliation are retained.
- Next: Complete the protected release-control chain before any buyer-specific external distribution.
- Proof routes: /pilot-workspace/access, /buyer-release-control-run, /pilot-deal-room
active
TrustOps Incident And Claims Control
Trust, safety, claims, and incident-readiness support for enterprise AI operations and buyer confidence.
Enterprise risk, legal, security, marketing, buyer diligence, and operator teams
- Packaged as governance support attached to pilots and enterprise readiness work.
- Operating model does not create managed 24/7 coverage, legal approval, public-claim approval, or certification by itself.
- Next: Keep buyer, investor, PR, advertising, and operator claims routed through Claim Guard before publication.
- Proof routes: /trust-safety-operations, /qa-claim-guard, /claims, /trust-center
external-review-required
Deployment Profile Advisory
Advisory package for managed cloud, private cloud, hospital-controlled, sovereign, and edge deployment readiness.
Security-sensitive hospitals, governments, sovereign programs, and infrastructure partners
- Premium planning motion that can expand into strategic platform partnership after legal/security review.
- Deployment profiles do not grant regional approval, data-residency approval, security certification, or procurement acceptance.
- Next: Attach qualified regional legal, privacy, security, and procurement review before external claims expand.
- Proof routes: /deployment-profiles, /global-reach, /market-activation, /interoperability
protected-gated
Interoperability Conformance Readiness
Conformance-readiness engagement around standards mapping, fixtures, synthetic tests, and live connector prerequisites.
IT, interoperability, EHR, payer, research, and device-integration reviewers
- Technical diligence package that supports pilots and future implementation scope.
- Synthetic conformance evidence is not live connector certification, trading-partner acceptance, or production data exchange authority.
- Next: Keep live connector claims blocked until buyer, legal, security, privacy, and partner approvals exist.
- Proof routes: /interoperability, /interoperability/evaluations, /integrations, /synthetic/validation
Competitive edge
The moat is proof-backed workflow infrastructure, not broad market language.
high
Healthcare Intelligence OS category position
SCRIMED combines AgentOS, Atlas Intelligence Core, TrustOS, workflows, interoperability, and buyer diligence into one healthcare operations layer.
The moat is domain workflow orchestration plus trust evidence, not general model access.
- Architecture proof is not production authorization or clinical validation.
- Proof routes: /healthcare-intelligence-os, /product, /agents, /atlas
high
TrustOS and Claim Guard discipline
Policy evaluation, claim control, blocked authority language, and no-authority headers are embedded across high-risk routes.
Healthcare buyers need governed explainability, boundaries, and audit posture before automation scale.
- Trust controls are readiness evidence, not legal advice or compliance certification.
- Proof routes: /trust-os, /qa-claim-guard, /claims, /api/product/console
high
Atlas evidence and Trust Cards
Evidence routes, Trust Cards, source intelligence, and workflow result packets create inspectable support for buyer review.
Evidence-backed workflow outputs are harder to copy than a model wrapper.
- Evidence organization does not guarantee clinical outcome, reimbursement, or customer revenue.
- Proof routes: /atlas, /trust, /source-intelligence, /workflows/results
high
Protected buyer release-control chain
Buyer release decisions, reviewer signoffs, disabled distribution lockbox controls, recipient controls, and access-log reconciliation are staged before external sharing.
Enterprise diligence friction becomes a managed product capability.
- Release-control readiness is not release approval or customer permission.
- Proof routes: /buyer-release-control-run, /pilot-workspace/access, /qa-buyer-proof-release
medium
Service Reliability fault/control map
Product/service controls, fault classes, efficiency improvements, open gates, and owners are inspectable before claims expand.
Operational maturity compounds as every new surface inherits route, smoke, and boundary checks.
- Reliability hardening is not security certification or approval authority.
- Proof routes: /service-reliability, /navigation, /release-continuity
medium
Public route and smoke discipline
Navigation Audit ties page inventory, API pattern count, route groups, smoke coverage, and protected fail-closed behavior together.
Route-count controls reduce drift as the product surface grows.
- Route control does not prove protected happy-path execution.
- Proof routes: /navigation, /api/navigation-audit, /api/navigation-audit/brief
medium
Public Market KPI and protected board metric ladder
KPI definitions, unit-economics packages, protected operator metrics, board scorecards, and finance methodology gates are mapped.
Operating metrics connect product usage, workflow value, and governance proof for diligence.
- KPI readiness is not audited financial reporting, valuation assurance, or securities material.
- Proof routes: /public-market-readiness, /api/public-market-readiness, /pilot-workspace/access
medium
Interoperability-first synthetic validation
Standards registry, fixture validation, conformance evaluations, and synthetic workflow validation are visible before live integration.
Healthcare integration readiness is encoded as a repeatable evidence system.
- Synthetic validation does not approve live connectors or PHI ingestion.
- Proof routes: /interoperability, /interoperability/evaluations, /integrations/fixture-validation
watch
Commercial packaging and sales operations linkage
Pricing tiers, pilot programs, Deal Room, Sales Operations, attribution, and buyer workspaces are connected.
Revenue operations become inspectable and tied to proof instead of ad hoc founder selling.
- Sales packaging does not guarantee conversion, revenue, customer permission, or procurement approval.
- Proof routes: /pricing, /pilot-deal-room, /sales-operations, /attribution-analytics
Investor readiness
Funding vitality improves when every investor question points to current proof and retained limits.
ready
Category narrative packaged
What is SCRIMED building that is bigger than a feature?
Healthcare Intelligence OS, public product console, and public-market thesis are live.
- Improves narrative clarity and makes the company easier to diligence.
- Narrative is operating posture, not an investment recommendation.
- Proof routes: /healthcare-intelligence-os, /product, /public-market-readiness
ready
Revenue streams mapped
How can SCRIMED make money before production clinical authority?
Assessments, synthetic pilots, governance audits, blueprints, diligence rooms, and advisory work are packaged.
- Shows near-term non-PHI, synthetic, and review-only revenue paths.
- Revenue capability is not a sales forecast, audited result, or customer commitment.
- Proof routes: /capital-vitality, /pricing, /market-activation
ready
Proof stack deployed
Is the product real, inspectable, and deployed?
Homepage, Hub, Product Console, Deal Room, APIs, briefs, smoke coverage, and production deployment exist.
- Reduces demo risk and gives reviewers direct inspection paths.
- Public proof stack does not prove protected customer production execution.
- Proof routes: /, /hub, /product, /pilot-deal-room
in-progress
Unit economics framework
Can SCRIMED measure cost, margin, and value by offer?
Public Market Readiness defines cost-per-workflow, gross margin by offer, protected operator metrics, and finance methodology gates.
- Creates the operating skeleton for future board and investor reporting.
- Framework is not audited financial reporting, accounting advice, tax advice, or valuation assurance.
- Proof routes: /public-market-readiness, /pilot-workspace/access
ready
Claims and approvals controls
Can SCRIMED grow without overclaiming regulated authority?
Approvals Readiness, Boundary Resolution, Clinical Authority Readiness, and Claim Guard are active.
- Improves credibility with regulated buyers and risk-aware investors.
- Controls do not replace counsel, security assessors, regulators, or buyer approvers.
- Proof routes: /approvals-readiness, /boundary-resolution, /clinical-authority-readiness, /qa-claim-guard
operator-required
Protected AAL2 proof retained
Can SCRIMED prove authenticated protected workflows without leaking secrets?
Protected Manual QA Evidence and Buyer Proof Release exist, with browser AAL2 session requirements.
- Creates a path from public demo proof into protected diligence proof.
- Protected happy-path proof requires approved human AAL2 operation and no token retention.
- Proof routes: /qa-aal2-run-evidence, /qa-manual-execution-console, /pilot-workspace/access
external-review-required
Funding data room sequence
Which documents can be shared externally and under what authority?
Buyer release-control chain can be repurposed as a funding-review release-control checklist.
- Clarifies how investor materials move through review without uncontrolled distribution.
- Funding materials require counsel and do not become securities offering material by default.
- Proof routes: /buyer-release-control-run, /pilot-workspace/access, /qa-buyer-proof-release
external-review-required
Security and compliance evidence path
What must happen before enterprise production trust claims?
Provider security review readiness, procurement evidence routing, and Approvals Readiness tracks are mapped.
- Shows a credible path toward enterprise-grade assurance without premature claims.
- Security posture is not SOC 2, HITRUST, HIPAA, pentest, or BAA execution.
- Proof routes: /approvals-readiness, /pilot-workspace/access, /trust-center
Funding workstreams
Capital readiness is operationalized as owned work, proof routes, and explicit review gates.
Use Capital Vitality as the executive growth lane: sell packaged synthetic and governance offers now, keep protected buyer/funding proof gated through AAL2 and release controls, refresh moat evidence before claims expand, and route any fundraising, valuation, securities, legal, reimbursement, security, PHI, or live-care claim through qualified external review.
packaged
Investor narrative brief
Use Capital Vitality brief as the top-level investor and board diligence summary.
Founder + Product Console
- Proof: /api/capital-vitality/brief
- Brief is not securities offering material or investment advice.
- Next: Review with counsel before using in fundraising or investor solicitation.
active
Pilot conversion proof
Tie Deal Room, pricing, pilot intake, sales operations, and attribution analytics into one conversion path.
Sales operations + Buyer Diligence
- Proof: /pilot-deal-room, /pricing, /sales-operations, /attribution-analytics
- Conversion proof is operating evidence, not customer revenue guarantee.
- Next: Keep every opportunity source, buyer segment, offer, and next action tagged.
operator-required
Unit economics and board metrics
Collect no-PHI operator metrics, board scorecards, rollups, and methodology gates in protected workspaces.
Finance + protected operator metrics owner
- Proof: /public-market-readiness and /pilot-workspace/access
- Protected metrics are not audited financial statements.
- Next: Use AAL2 protected capture for real operating metrics and preserve methodology notes.
external-review-required
Security and compliance review packet
Package provider security reviews, procurement evidence routing, and approval tracks.
Security + legal + qualified external reviewers
- Proof: /approvals-readiness and /pilot-workspace/access
- Readiness packet is not security certification or legal approval.
- Next: Retain qualified reviewers before enterprise assurance language expands.
external-review-required
Customer reference and public proof permission
Use release-control chain before any customer-specific evidence, logo, case study, or testimonial is shared.
Buyer Diligence + Release Steward + counsel
- Proof: /buyer-release-control-run
- No public customer proof is allowed without explicit approval and retained release evidence.
- Next: Keep distribution lockbox disabled until reviewer signoffs and recipient/access controls exist.
active
Offer packaging and pricing discipline
Keep assessments, pilots, governance audits, blueprints, protected pilots, and strategic partnerships packaged.
Enterprise sales + product
- Proof: /pricing
- Pricing is non-binding and does not imply production authority or procurement acceptance.
- Next: Use fixed scopes and clear upgrade paths to protect margin and reduce buyer ambiguity.
active
Competitive edge proof refresh
Maintain moat signals as proof-backed operating claims rather than broad market assertions.
Founder + market activation + source intelligence
- Proof: /competitive-edge, /source-intelligence, /market-activation
- Competitive positioning cannot imply third-party endorsement, partnership, certification, or guaranteed outcomes.
- Next: Refresh proof routes when product capabilities or external review posture changes.
external-review-required
Legal and securities review
Separate operating readiness from fundraising solicitation, securities material, valuation, and investor advice.
Founder + qualified counsel
- Proof: /capital-vitality and /public-market-readiness
- SCRIMED cannot self-authorize investment materials or securities offering language.
- Next: Run any investor solicitation, SAFE/equity note, valuation, or offering deck through counsel.